Among these, IL-33 and IL-18 play key roles in tumor biology and immunology in different types of cancers, including breast, CRC, and CML [16, 39, 45–47]. This evidence concerns the gene IL18 and chronic myelogenous leukemia, BCR-ABL1 positive.